B/BE/20/BVW4 - Fiche d'information destinée au public (préparée par le notifiant)

Trial reference: 
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy